Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Autoimmune Disorders

  Free Subscription

Articles published in J Rheumatol

Retrieve available abstracts of 112 articles:
HTML format

Single Articles

    June 2022
  1. LV C, You H, Xu L, Wang L, et al
    Coexisting of anti-Ro52 autoantibodies on anti-MDA5 autoantibodies-positive dermatomyositis is highly associated with rapidly progressive interstitial lung disease and mortality risk.
    J Rheumatol. 2022 Jun 15. pii: jrheum.220139. doi: 10.3899/jrheum.220139.
    PubMed     Abstract available

  2. SIMONS G, Falahee M
    Fear of the Unknown: Can We Help Individuals With a Systemic Autoimmune Rheumatic Disease Deal With Uncertainty?
    J Rheumatol. 2022 Jun 1. pii: jrheum.220502. doi: 10.3899/jrheum.220502.
    PubMed     Abstract available

  3. MARINO A, Orsini F, Pregnolato F, Cimaz R, et al
    Tumor Necrosis Factor-alpha Inhibition Before and After Rituximab Treatment in Juvenile Idiopathic Arthritis: What Shall We Expect? A Pilot Study.
    J Rheumatol. 2022;49:654-656.

  4. BOLHUIS TE, Nizet LEA, Owen C, den Broeder AA, et al
    Measurement Properties of the Polymyalgia Rheumatica Activity Score: A Systematic Literature Review.
    J Rheumatol. 2022;49:627-634.
    PubMed     Abstract available

  5. MAHESWARANATHAN M, Eudy AM, Barr AC, Howe C, et al
    Association of Health Literacy and Numeracy With Lupus Knowledge and the Creation of the Lupus Knowledge Assessment Test.
    J Rheumatol. 2022;49:585-591.
    PubMed     Abstract available

    May 2022
  6. MINIAOUI I, Morel N, Levesque K, Maltret A, et al
    Health Outcome of 215 Mothers of Children with Autoimmune Congenital Heart Block: Analysis of the French Neonatal Lupus Syndrome Registry.
    J Rheumatol. 2022 May 2. pii: jrheum.210703. doi: 10.3899/jrheum.210703.
    PubMed     Abstract available

  7. MCHUGH A, Chan A, Herrera C, Park JM, et al
    Profiling Behavioral and Psychological Symptoms in Children Undergoing Treatment for Spondyloarthritis and Polyarthritis.
    J Rheumatol. 2022;49:489-496.
    PubMed     Abstract available

  8. EL TAL T, Ryan ME, Feldman BM, Bingham CA, et al
    Consensus Approach to a Treat-to-target Strategy in Juvenile Idiopathic Arthritis Care: Report From the 2020 PR-COIN Consensus Conference.
    J Rheumatol. 2022;49:497-503.
    PubMed     Abstract available

    April 2022
  9. LALLY L, Narula N, Goodfellow N, Luqmani R, et al
    Rho Kinase Expression in Giant Cell Arteritis: Validating pERM Intensity Score to Increase Sensitivity of Temporal Artery Biopsy.
    J Rheumatol. 2022 Apr 15. pii: jrheum.220012. doi: 10.3899/jrheum.220012.
    PubMed     Abstract available

  10. KUWANA M, Wakasugi N, Furuya T, Uno S, et al
    Tacrolimus in patients with interstitial pneumonia associated with polymyositis or dermatomyositis: interim report of post-marketing surveillance in Japan.
    J Rheumatol. 2022 Apr 15. pii: jrheum.210322. doi: 10.3899/jrheum.210322.
    PubMed     Abstract available

  11. WALLACE ZS, Cook C, Finkelstein-Fox L, Fu X, et al
    The Association of Illness-Related Uncertainty with Mental Health in Systemic Autoimmune Rheumatic Diseases.
    J Rheumatol. 2022 Apr 1. pii: jrheum.211084. doi: 10.3899/jrheum.211084.
    PubMed     Abstract available

  12. NOONE DG, Silverman ED
    Treatment of Childhood-onset Proliferative Lupus Nephritis in the 21st Century: A Call to Catch Up With the Evidence.
    J Rheumatol. 2022 Apr 1. pii: jrheum.220196. doi: 10.3899/jrheum.220196.
    PubMed     Abstract available

  13. GIANCANE G, Papa R, Vastert S, Bagnasco F, et al
    Anakinra in Patients With Systemic Juvenile Idiopathic Arthritis: Long-term Safety From the Pharmachild Registry.
    J Rheumatol. 2022;49:398-407.
    PubMed     Abstract available

    March 2022
  14. MCDERMOTT G, Gill R, Gagne S, Byrne S, et al
    Demographic, Lifestyle, and Serologic Risk Factors for Rheumatoid Arthritis-Associated Bronchiectasis: Role of RA-related Autoantibodies.
    J Rheumatol. 2022 Mar 15. pii: jrheum.211242. doi: 10.3899/jrheum.211242.
    PubMed     Abstract available

  15. HADWEN B, Yu R, Cairns E, Barra L, et al
    Presence of Autoantibodies in Males and Females with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
    J Rheumatol. 2022 Mar 15. pii: jrheum.211020. doi: 10.3899/jrheum.211020.
    PubMed     Abstract available

  16. LIU Y, Xiao F, Zhang R, Zhang X, et al
    Alterations of Plasma Microbiome: A Potentially New Perspective to the Dysbiosis in Systemic Lupus Erythematosus?
    J Rheumatol. 2022 Mar 15. pii: jrheum.220023. doi: 10.3899/jrheum.220023.
    PubMed     Abstract available

  17. SUN G, Yafasova A, Baslund B, Faurschou M, et al
    Long-term Risk of Heart Failure and Other Adverse Cardiovascular Outcomes in Granulomatosis With Polyangiitis: A Nationwide Cohort Study.
    J Rheumatol. 2022;49:291-298.
    PubMed     Abstract available

    February 2022
  18. JAMES W, Ogunrinde E, Wan Z, Kamen DL, et al
    A distinct plasma microbiome but not gut microbiome in patients with systemic lupus erythematosus compared to healthy individuals.
    J Rheumatol. 2022 Feb 15. pii: jrheum.210952. doi: 10.3899/jrheum.210952.
    PubMed     Abstract available

  19. CANNON L, Wenderfer SE, Lewandowski LB, Cooper JC, et al
    Use of EuroLupus Cyclophosphamide Dosing for the Treatment of Lupus Nephritis in Childhood-onset Systemic Lupus Erythematosus in North America.
    J Rheumatol. 2022 Feb 15. pii: jrheum.210428. doi: 10.3899/jrheum.210428.
    PubMed     Abstract available

  20. CHANG Y, Di W, Wu J
    Systemic Lupus Erythematosus Increases the Risk of Gestational Diabetes: Truth or Illusion?
    J Rheumatol. 2022 Feb 1. pii: jrheum.211374. doi: 10.3899/jrheum.211374.
    PubMed     Abstract available

  21. PEREZ ACOSTA ME, Meyers AB, Toth MB
    Cystic Ganglionosis in a 3-year-old Mimicking Juvenile Idiopathic Arthritis.
    J Rheumatol. 2022;49:230-231.

    January 2022
  22. FAIR DC, Nocton JJ, Panepinto JA, Yan K, et al
    Anxiety and Depressive Symptoms in Juvenile Idiopathic Arthritis Correlate With Pain and Stress Using PROMIS Measures.
    J Rheumatol. 2022;49:74-80.
    PubMed     Abstract available

    December 2021
  23. LI Z, Li D, Lv P, Liu J, et al
    Brain Abscess Due to Nocardia in a Patient With Systemic Lupus Erythematosus.
    J Rheumatol. 2021 Dec 1. pii: jrheum.210971. doi: 10.3899/jrheum.210971.
    PubMed     Abstract available

  24. VAN VOLLENHOVEN RF, Hahn BH, Tsokos GC, Lipsky P, et al
    Efficacy and Safety of Ustekinumab in Patients with Active Systemic Lupus Erythematosus: Results Through 2 Years of an Open-Label Extension in a Phase 2 Study.
    J Rheumatol. 2021 Dec 1. pii: jrheum.210805. doi: 10.3899/jrheum.210805.
    PubMed     Abstract available

  25. GERNAAT SAM, Simard JF, Wikstrom AK, Svenungsson E, et al
    Gestational Diabetes Mellitus Risk in Pregnant Women with Systemic Lupus Erythematosus.
    J Rheumatol. 2021 Dec 1. pii: jrheum.210087. doi: 10.3899/jrheum.210087.
    PubMed     Abstract available

  26. TOUSSIROT E, Michaud M, Wendling D, Devauchelle V, et al
    Abatacept as Adjunctive Therapy in Refractory Polymyalgia Rheumatica.
    J Rheumatol. 2021;48:1888-1889.

  27. DAVE I, Estroff B, Gergely T, Rostad CA, et al
    Impact of the Season of Birth on the Development of Juvenile Idiopathic Arthritis in the United States: A Nationwide Registry-based Study.
    J Rheumatol. 2021;48:1856-1862.
    PubMed     Abstract available

  28. AESCHLIMANN FA, Raimondi F, Leiner T, Aquaro GD, et al
    Overview of imaging in adult- and childhood-onset Takayasu arteritis.
    J Rheumatol. 2021 Dec 1. pii: jrheum.210368. doi: 10.3899/jrheum.210368.
    PubMed     Abstract available

    November 2021
  29. IWAMOTO T, Dorschner JM, Selvaraj S, Mezzano V, et al
    High Systemic Type I Interferon Activity is Associated with Active Class III/IV Lupus Nephritis.
    J Rheumatol. 2021 Nov 15. pii: jrheum.210391. doi: 10.3899/jrheum.210391.
    PubMed     Abstract available

  30. CURTIS JR, Zhou X, Rubin DT, Reinisch W, et al
    Characteristics, Comorbidities, and Outcomes of SARS-CoV-2 Infection in Patients with Autoimmune Conditions Treated with Systemic Therapies: a Population-based Study.
    J Rheumatol. 2021 Nov 15. pii: jrheum.210888. doi: 10.3899/jrheum.210888.
    PubMed     Abstract available

  31. WOJCIK S, Inman RD, Nakamura A
    IgG4-related Disease in a Patient With Ankylosing Spondylitis: Clues to Common Immunopathogenesis.
    J Rheumatol. 2021;48:1757-1758.

  32. MENDEL A, Pagnoux C
    Use of Rituximab for the Treatment of Antineutrophil Cytoplasm Antibody-associated Vasculitis in Canada, 2010-2020.
    J Rheumatol. 2021;48:1755-1756.

  33. SPRINGER JM, Funk RS
    Dose-dependent Pharmacological Response to Rituximab in the Treatment of Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
    J Rheumatol. 2021;48:1718-1724.
    PubMed     Abstract available

  34. BERARD R, Batthish M
    Addressing Healthcare Quality in Juvenile Idiopathic Arthritis With a Universal Access Program.
    J Rheumatol. 2021;48:1635-1638.

  35. CONCHA S, Morales PS, Talesnik E, Borzutzky A, et al
    Changes in Treatments and Outcomes After Implementation of a National Universal Access Program for Juvenile Idiopathic Arthritis.
    J Rheumatol. 2021;48:1725-1731.
    PubMed     Abstract available

    October 2021
  36. CARBONE T, Picerno V, Pafundi V, Esposito E, et al
    Impact of COVID-19 pandemic on appropriateness of diagnostic pathways of autoimmune diseases.
    J Rheumatol. 2021 Oct 15. pii: jrheum.210611. doi: 10.3899/jrheum.210611.
    PubMed     Abstract available

  37. GOULENOK T, Francois C, Mendes C, Farhi F, et al
    Improving COVID-19 vaccine coverage in patients with autoimmune and inflammatory diseases.
    J Rheumatol. 2021 Oct 15. pii: jrheum.210534. doi: 10.3899/jrheum.210534.
    PubMed     Abstract available

  38. SAURET A, Stievenart J, Smets P, Olagne L, et al
    Case of Giant Cell Arteritis After SARS-CoV-2 Vaccination: A Particular Phenotype?
    J Rheumatol. 2021 Oct 1. pii: jrheum.210724. doi: 10.3899/jrheum.210724.
    PubMed     Abstract available

  39. ULLOA AC, Liao F, Carlomagno RL, Dia T, et al
    Schizophrenia Genetics and Neuropsychiatric Features in Childhood-Onset Systemic Lupus Erythematosus.
    J Rheumatol. 2021 Oct 1. pii: jrheum.210363. doi: 10.3899/jrheum.210363.
    PubMed     Abstract available

  40. ROSS C, Elfassy HL, Makhzoum JP
    Somatic Mutation in UBA1 and ANCA-associated Vasculitis.
    J Rheumatol. 2021;48:1626-1627.

    September 2021
  41. LIEBER SB, Nahid M, Paget S, Berman JR, et al
    Evaluation of a Patient-Reported Frailty Tool in Women with Systemic Lupus Erythematosus.
    J Rheumatol. 2021 Sep 1. pii: jrheum.201466. doi: 10.3899/jrheum.201466.
    PubMed     Abstract available

    August 2021
  42. WANG X, Hefton A, Ni K, Ukadike KC, et al
    Autoantibodies against unmodified and citrullinated human endogenous retrovirus K envelope protein in rheumatoid arthritis patients.
    J Rheumatol. 2021 Aug 1. pii: jrheum.201492. doi: 10.3899/jrheum.201492.
    PubMed     Abstract available

  43. FALASINNU T, Drenkard C, Bao G, Mackey S, et al
    The Problem of Pain in Systemic Lupus Erythematosus: An Explication of the Role of Biopsychosocial Mechanisms.
    J Rheumatol. 2021;48:1279-1289.
    PubMed     Abstract available

    July 2021
  44. RUPERTO N, Brunner HI, Tzaribachev N, Vega-Cornejo G, et al
    Absence of Association Between Abatacept Exposure and Initial Infection in Patients With Juvenile Idiopathic Arthritis.
    J Rheumatol. 2021;48:1073-1081.
    PubMed     Abstract available

  45. ZHAO Y, Iyer RS, Thapa M, Biswas D, et al
    A Novel Algorithm using Within-leg Calibration for Enhanced Accuracy of Detection of Arthritis by Infrared Thermal Imaging in Children.
    J Rheumatol. 2021 Jul 1. pii: jrheum.210077. doi: 10.3899/jrheum.210077.
    PubMed     Abstract available

    June 2021
    Hyperferritinemia Wins Again: Defining Macrophage Activation Syndrome in Pediatric Systemic Lupus Erythematosus.
    J Rheumatol. 2021 Jun 15. pii: jrheum.210024. doi: 10.3899/jrheum.210024.
    PubMed     Abstract available

  47. AL AWQATI MZ, Sluzevich JC, Berianu F
    Ulcerative Paraneoplastic Dermatomyositis in the Setting of Positive Transcriptional Intermediary Factor 1-gamma Antibody.
    J Rheumatol. 2021 Jun 15. pii: jrheum.200399. doi: 10.3899/jrheum.200399.
    PubMed     Abstract available

    Giant Cell Arteritis: Real-life Experience.
    J Rheumatol. 2021 Jun 1. pii: jrheum.210334. doi: 10.3899/jrheum.210334.
    PubMed     Abstract available

  49. GROOT N, Kardolus A, Bijl M, Dolhain RJEM, et al
    Effects of Childhood-onset Systemic Lupus Erythematosus on Academic Achievements and Employment in Adult Life.
    J Rheumatol. 2021;48:915-923.
    PubMed     Abstract available

    May 2021
  50. HAZLEWOOD GS, Pardo J, Barnabe C, Schieir O, et al
    Canadian Rheumatology Association recommendation for the use of COVID-19 vaccination for patients with autoimmune rheumatic diseases.
    J Rheumatol. 2021 May 15. pii: jrheum.210288. doi: 10.3899/jrheum.210288.
    PubMed     Abstract available

  51. RAHMAN A
    Why Do Patients With Systemic Lupus Erythematosus Suffer Pain?
    J Rheumatol. 2021 May 1. pii: jrheum.210057. doi: 10.3899/jrheum.210057.
    PubMed     Abstract available

  52. REZAEI E, Newkirk MM, Li Z, Gordon JR, et al
    Soluble Low-density Lipoprotein Receptor-related Protein 1 in Juvenile Idiopathic Arthritis.
    J Rheumatol. 2021;48:760-766.
    PubMed     Abstract available

    April 2021
  53. DIAZ T, Dominguez D, Jaeggi E, Knight A, et al
    Ethnicity and Neonatal Lupus Erythematosus Manifestations Risk in a Large Multi-Ethnic Cohort.
    J Rheumatol. 2021 Apr 1. pii: jrheum.201338. doi: 10.3899/jrheum.201338.
    PubMed     Abstract available

  54. LANGLEBEN D, Berkson L, Chartrand S
    Selexipag Therapy for Raynaud Phenomenon-induced Severe Digital Ischemia in Intravenous Epoprostenol Responders With Connective Tissue Disease.
    J Rheumatol. 2021;48:616-617.

  55. JAYNE D
    Antineutrophil Cytoplasmic Antibody-associated Vasculitis Management 2020: Where Are We Now?
    J Rheumatol. 2021;48:479-481.

  56. SCHNEIDER J, Venhoff N, Walz G
    Ruptured Intrarenal Arterial Aneurysm in a Patient With Granulomatosis With Polyangiitis.
    J Rheumatol. 2021;48:615.

  57. GKROUZMAN E, Sevim E, Finik J, Andrade D, et al
    Antiphospholipid Antibody Profile Stability Over Time: Prospective Results From the APS ACTION Clinical Database and Repository.
    J Rheumatol. 2021;48:541-547.
    PubMed     Abstract available

  58. MENDEL A, Ennis D, Go E, Bakowsky V, et al
    CanVasc Consensus Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitis: 2020 Update.
    J Rheumatol. 2021;48:555-566.
    PubMed     Abstract available

  59. LUO Y, Xu J, Jiang C, Krittanawong C, et al
    Trends in the Inpatient Burden of Coronary Artery Disease in Granulomatosis With Polyangiitis: A Study of a Large National Dataset.
    J Rheumatol. 2021;48:548-554.
    PubMed     Abstract available

  60. MALLER J, Fox E, Park KT, Paul SS, et al
    Inflammatory Bowel Disease in Children With Systemic Juvenile Idiopathic Arthritis.
    J Rheumatol. 2021;48:567-574.
    PubMed     Abstract available

    March 2021
    The Variability of Antinuclear Antibody Testing.
    J Rheumatol. 2021 Mar 15. pii: jrheum.210039. doi: 10.3899/jrheum.210039.
    PubMed     Abstract available

  62. MOHAMMAD AJ, Turkiewicz A, Stamatis P, Turesson C, et al
    Trajectory of Healthcare Resources Utilization in Giant Cell Arteritis - A Population-Based Study.
    J Rheumatol. 2021 Mar 1. pii: jrheum.201131. doi: 10.3899/jrheum.201131.
    PubMed     Abstract available

    Stroke is Different in Systemic Lupus Erythematosus: Implications for Survival and Functionality.
    J Rheumatol. 2021 Mar 1. pii: jrheum.201209. doi: 10.3899/jrheum.201209.
    PubMed     Abstract available

  64. BERTI A, Specks U
    The Survival of Patients With Alveolar Hemorrhage Secondary to Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
    J Rheumatol. 2021;48:314-317.

    What It Means to Me to Have Juvenile Arthritis: One Patient's Definition.
    J Rheumatol. 2021;48:470.

  66. TANG S, Li X, Zhao KY, Zhou Q, et al
    Clinical Characteristics and Prognostic Analysis of Microscopic Polyangiitis With Diffuse Alveolar Hemorrhage.
    J Rheumatol. 2021;48:410-416.
    PubMed     Abstract available

  67. ONO N, Inoue Y, Miyamura T, Ueda N, et al
    The Association of Airway Comorbidities With the Clinical Phenotypes and Outcomes of Patients With Antineutrophil Cytoplasmic Autoantibody-associated Vasculitis.
    J Rheumatol. 2021;48:417-425.
    PubMed     Abstract available

    February 2021
  68. CLEMENT J, Duffau P, Constans J, Schaeverbeke T, et al
    Real-world risk of relapse of giant cell arteritis treated with tocilizumab: A retrospective analysis of 43 patients.
    J Rheumatol. 2021 Feb 15. pii: jrheum.200952. doi: 10.3899/jrheum.200952.
    PubMed     Abstract available

  69. VYNCKIER J, Demeestere J, Lambert J
    Black-blood Magnetic Resonance Imaging in Giant Cell Arteritis.
    J Rheumatol. 2021;48:301-302.

  70. KORKUS D, Gazitt T, Cohen AD, Feldhamer I, et al
    Increased Prevalence of Systemic Lupus Erythematosus Comorbidity in Patients With Psoriatic Arthritis: A Population-based Case-control Study.
    J Rheumatol. 2021;48:207-213.
    PubMed     Abstract available

  71. PETRI M, Barr E, Magder LS
    Risk of Renal Failure Within 10 or 20 Years of Systemic Lupus Erythematosus Diagnosis.
    J Rheumatol. 2021;48:222-227.
    PubMed     Abstract available

  72. WALSCHEID K, Glandorf K, Rothaus K, Niewerth M, et al
    Enthesitis-related Arthritis: Prevalence and Complications of Associated Uveitis in Children and Adolescents From a Population-based Nationwide Study in Germany.
    J Rheumatol. 2021;48:262-269.
    PubMed     Abstract available

    January 2021
    Update on Sweet Syndrome in Eosinophilic Granulomatosis With Polyangiitis.
    J Rheumatol. 2021;48:151.

    December 2020
  74. ORLANDI M, Landini N, Bruni C, Colagrande S, et al
    Infection or autoimmunity? The clinical challenge of interstitial lung disease in systemic sclerosis during COVID 19 pandemic.
    J Rheumatol. 2020 Dec 1. pii: jrheum.200832. doi: 10.3899/jrheum.200832.
    PubMed     Abstract available

  75. GERSTEIN M, Borgia RE, Dominguez D, Feldman BM, et al
    Predicting macrophage activation syndrome (MAS) in childhood-onsetsystemic lupus erythematosus (cSLE) patients at diagnosis.
    J Rheumatol. 2020 Dec 1. pii: jrheum.200292. doi: 10.3899/jrheum.200292.
    PubMed     Abstract available

    November 2020
  76. GEORGE M, Venkatachalam S, Banerjee S, Baker JF, et al
    Concerns, healthcare use, and treatment interruptions in patients with common autoimmune rheumatic diseases during the COVID-19 pandemic.
    J Rheumatol. 2020 Nov 15. pii: jrheum.201017. doi: 10.3899/jrheum.201017.
    PubMed     Abstract available

  77. ROSINA S, Varnier GC, Pistorio A, Pilkington C, et al
    Development and testing of reduced versions of the MMT-8 in juvenile dermatomyositis.
    J Rheumatol. 2020 Nov 15. pii: jrheum.200543. doi: 10.3899/jrheum.200543.
    PubMed     Abstract available

  78. BATU ED, Kaya Akca U, Pac Kisaarslan A, Sag E, et al
    The performances of the ACR 1997, SLICC 2012, and EULAR/ACR 2019 classification criteria in pediatric systemic lupus erythematosus.
    J Rheumatol. 2020 Nov 15. pii: jrheum.200871. doi: 10.3899/jrheum.200871.
    PubMed     Abstract available

  79. LAMBERS WM, Westra J, Bootsma H, de Leeuw K, et al
    Hydroxychloroquine suppresses interferon-inducible genes and B-cell activating factor in patients with incomplete and new onset systemic lupus erythematosus.
    J Rheumatol. 2020 Nov 15. pii: jrheum.200726. doi: 10.3899/jrheum.200726.
    PubMed     Abstract available

  80. ZHANG B, Chi H, Su Y
    Near Tetraploidy in a Patient with Systemic Lupus Erythematosus.
    J Rheumatol. 2020;47:1725-1726.

  81. FAYE AS, Lee KE, Laszkowska M, Kim J, et al
    Risk of Adverse Outcomes in Hospitalized Patients with Autoimmune Disease and COVID-19: A Matched Cohort Study from New York City.
    J Rheumatol. 2020 Nov 1. pii: jrheum.200989. doi: 10.3899/jrheum.200989.
    PubMed     Abstract available

  82. GAMWELL KL, Hommel KA
    Comprehensive Care in Pediatric Rheumatic Diseases: A Multifaceted Challenge.
    J Rheumatol. 2020;47:1603-1605.

    October 2020
  83. KIM JW, Jung JY, Kim HA, Yang JI, et al
    Lupus Low Disease Activity State achievement is important for reducing adverse outcomes in pregnant patients with systemic lupus erythematosus.
    J Rheumatol. 2020 Oct 15. pii: jrheum.200802. doi: 10.3899/jrheum.200802.
    PubMed     Abstract available

  84. DOMINGUEZ D, Kamphuis S, Beyene J, Wither J, et al
    Relationship between Genetic Risk and Age of Diagnosis of Systemic Lupus Erythematosus.
    J Rheumatol. 2020 Oct 15. pii: jrheum.200002. doi: 10.3899/jrheum.200002.
    PubMed     Abstract available

  85. MEHTA P, Sattui SE, van der Geest K, Brouwer E, et al
    Giant cell arteritis and COVID-19: similarities and discriminators, a systematic literature review.
    J Rheumatol. 2020 Oct 15. pii: jrheum.200766. doi: 10.3899/jrheum.200766.
    PubMed     Abstract available

    September 2020
  86. TROUNG L, Pourzand L, Volkmann ER
    Covid-19 in Patients with Connective Tissue Disease-Related Interstitial Lung Disease.
    J Rheumatol. 2020 Sep 15. pii: jrheum.201064. doi: 10.3899/jrheum.201064.
    PubMed     Abstract available

  87. SALAMA AD, Caplin B
    Lupus Nephritis and Chronic Kidney Disease.
    J Rheumatol. 2020;47:1303-1304.

  88. TSELIOS K, Gladman DD, Taheri C, Su J, et al
    Factors Associated with Rapid Progression to End Stage Kidney Disease in Lupus Nephritis.
    J Rheumatol. 2020 Sep 1. pii: jrheum.200161. doi: 10.3899/jrheum.200161.
    PubMed     Abstract available

  89. TSOI LK, Mok CC, Man BL, Fu YP, et al
    Imaging pattern and outcome of stroke in patients with systemic lupus erythematosus: a case-control study.
    J Rheumatol. 2020 Sep 1. pii: jrheum.200664. doi: 10.3899/jrheum.200664.
    PubMed     Abstract available

    August 2020
    APOL1 Gene - Implications for Systemic Lupus Erythematosus.
    J Rheumatol. 2020;47:1155-1157.

    July 2020
  91. ALMAGHLOUTH I, Pullenayegum E, Gladman DD, Urowitz MB, et al
    Propensity Score Methods in Rare Disease. A Demonstration Using Observational Data in Systemic Lupus Erythematosus.
    J Rheumatol. 2020 Jul 1. pii: jrheum.200254. doi: 10.3899/jrheum.200254.
    PubMed     Abstract available

  92. MURIMI IB, Lin DH, Kan H, Tierce J, et al
    Health Care Utilization and Costs of Systemic Lupus Erythematosus by Disease Severity in the United States.
    J Rheumatol. 2020 Jul 1. pii: jrheum.191187. doi: 10.3899/jrheum.191187.
    PubMed     Abstract available

    June 2020
  93. QUEVEDO-ABELEDO JC, Sanchez-Perez H, Tejera-Segura B, de Armas-Rillo L, et al
    Higher Prevalence and Degree of Insulin Resistance in Patients with Rheumatoid Arthritis than in Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2020 Jun 15. pii: jrheum.200435. doi: 10.3899/jrheum.200435.
    PubMed     Abstract available

  94. FAVALLI EG, Agape E, Caporali R
    Are patients with systemic lupus erythematosus at increased risk of severe COVID-19?
    J Rheumatol. 2020 Jun 1. pii: jrheum.200723. doi: 10.3899/jrheum.200723.
    PubMed     Abstract available

    Possible Consequences of a Shortage of Hydroxychloroquine for Patients with Systemic Lupus Erythematosus amid the COVID-19 Pandemic.
    J Rheumatol. 2020;47:787-790.

  96. SO H, Mak JWY, Tam LS
    No Systemic Lupus Erythematosus with COVID-19 in Hong Kong: The Effect of Masking?
    J Rheumatol. 2020 Jun 1. pii: jrheum.200605. doi: 10.3899/jrheum.200605.
    PubMed     Abstract available

  97. STOUSTRUP P, Twilt M, Herlin T
    Systemic Treatment for Temporomandibular Joint Arthritis in Juvenile Idiopathic Arthritis.
    J Rheumatol. 2020;47:793-795.

    May 2020
  98. STAMATIS P, Turkiewicz A, Englund M, Jonsson G, et al
    Infections are associated with increased risk of giant cell arteritis - a population-based case-control study from Southern Sweden.
    J Rheumatol. 2020 May 15. pii: jrheum.200211. doi: 10.3899/jrheum.200211.
    PubMed     Abstract available

  99. CHEN C, Yao B, Yan M, Su K, et al
    The plight of patients with lupus nephritis in Wuhan, China.
    J Rheumatol. 2020 May 8. pii: jrheum.200452. doi: 10.3899/jrheum.200452.
    PubMed     Abstract available

  100. SILVA-DIAZ M, Freire Gonzalez M, Romero TH
    Pulmonary Alveolar Proteinosis in a Patient with Systemic Lupus Erythematosus.
    J Rheumatol. 2020;47:779-780.

  101. TURK MA, Hayworth JL, Nevskaya T, Pope JE, et al
    Ocular manifestations in rheumatoid arthritis, connective tissue disease and vasculitis: a systematic review and meta-analysis.
    J Rheumatol. 2020 May 1. pii: jrheum.190768. doi: 10.3899/jrheum.190768.
    PubMed     Abstract available

  102. KWAK SG, Par SH, Kim JY
    Incidence and prevalence of juvenile systemic lupus erythematosus in Korea: data from the national health claims database 2017.
    J Rheumatol. 2020 May 1. pii: jrheum.191186. doi: 10.3899/jrheum.191186.
    PubMed     Abstract available

    April 2020
  103. FAVALLI EG, Agape E, Caporali R
    Incidence and clinical course of COVID-19 in patients with connective tissue diseases: a descriptive observational analysis.
    J Rheumatol. 2020 Apr 25. pii: jrheum.200507. doi: 10.3899/jrheum.200507.
    PubMed     Abstract available

  104. ERNSTE FC, Chong C, Crowson CS, Kermani TA, et al
    Functional Index-3: A Valid and Reliable Functional Outcome Assessment Measure in Dermatomyositis and Polymyositis Patients.
    J Rheumatol. 2020 Apr 15. pii: jrheum.191374. doi: 10.3899/jrheum.191374.
    PubMed     Abstract available

  105. TSELIOS K, Gladman DD, Su J, Urowitz MB, et al
    Advanced Chronic Kidney Disease in Lupus Nephritis: Is Dialysis Inevitable?
    J Rheumatol. 2020 Apr 1. pii: jrheum.191064. doi: 10.3899/jrheum.191064.
    PubMed     Abstract available

  106. TAKEUCHI T, Wakasugi N, Makino H
    Long-term safety and effectiveness of tacrolimus in lupus nephritis patients: 5- year interim post-marketing surveillance study in Japan (TRUST).
    J Rheumatol. 2020 Apr 1. pii: jrheum.191008. doi: 10.3899/jrheum.191008.
    PubMed     Abstract available

  107. LIU K, Tomlinson G, Reed AM, Huber AM, et al
    Pilot study of the juvenile dermatomyositis consensus treatment plans: a CARRA Registry study.
    J Rheumatol. 2020 Apr 1. pii: jrheum.190494. doi: 10.3899/jrheum.190494.
    PubMed     Abstract available

  108. UROWITZ MB, Gladman DD, Ibanez D, Su J, et al
    Impact of disease activity on organ damage progression in systemic lupus erythematosus: University of Toronto Lupus Clinic Cohort.
    J Rheumatol. 2020 Apr 1. pii: jrheum.190259. doi: 10.3899/jrheum.190259.
    PubMed     Abstract available

    September 2019
  109. BOLLHALDER A, Patcas R, Eichenberger M, Muller L, et al
    Magnetic Resonance Imaging Follow-up of Temporomandibular Joint Inflammation, Deformation and Mandibular Growth in Juvenile Idiopathic Arthritis Patients on Systemic Treatment.
    J Rheumatol. 2019 Sep 15. pii: jrheum.190168. doi: 10.3899/jrheum.190168.
    PubMed     Abstract available

    March 2019
  110. BANERJEE S, Quinn KA, Gribbons KB, Rosenblum JS, et al
    Effect of Treatment on Imaging, Clinical, and Serologic Assessments of Disease Activity in Large-Vessel Vasculitis.
    J Rheumatol. 2019 Mar 15. pii: jrheum.181222. doi: 10.3899/jrheum.181222.
    PubMed     Abstract available

    February 2019
  111. OTOBO TM, Conaghan PG, Maksymowych WP, van der Heijde D, et al
    Preliminary Definitions for Sacroiliac Joint Pathologies in the OMERACT Juvenile Idiopathic Arthritis MRI Score (OMERACT JAMRIS-SIJ).
    J Rheumatol. 2019 Feb 15. pii: jrheum.181115. doi: 10.3899/jrheum.181115.
    PubMed     Abstract available

    November 2018
  112. PRADSGAARD DO, Horlyck A, Spannow AH, Heuck C, et al
    A Comparison of Radiographic Joint Space Width Measurements Versus Ultrasonographic Assessment of Cartilage Thickness in Children with Juvenile Idiopathic Arthritis.
    J Rheumatol. 2018 Nov 15. pii: jrheum.170571. doi: 10.3899/jrheum.170571.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.